Are these the best healthcare shares to buy on the ASX?

Are Cochlear Limited (ASX:COH) shares and two others the best healthcare shares to buy on the Australian share market right now?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the last five years the S&P/ASX 200 Health Care index has put on a staggering gain of 97% excluding dividends.

This is vastly superior to the gains that were made by the S&P/ASX 200 over the same period, even including dividends.

While this level of outperformance may be unlikely over the next five years, I believe the quality in the sector means there's a good chance that some level of outperformance will occur.

With that in mind, I think it could be well worth gaining exposure to the sector. Here are my top three shares in the sector right now:

Cochlear Limited (ASX: COH)

Last month this hearing solutions company reiterated its guidance for FY 2019 when it held its annual general meeting. It expects to deliver a reported net profit of $265 million to $275 million, which will be a year on year increase of between 8% and 12%. The good news is that I believe this level of growth will be possible over the medium to long term thanks to its exposure to the global ageing populations tailwind.

CSL Limited (ASX: CSL)

My top pick in the healthcare sector would have to be this global biotech company. Especially now that its shares have pulled back meaningfully over the last couple of months. CSL's shares are down 22% from their 52-week high and at a level which I think is very attractive for investors that are looking for buy and hold options. Due to the quality of its management team, growing plasma collection network, strong core business, lucrative pipeline of products, and fast-growing influenza business, I believe CSL can continue growing its earnings at an above-average rate for many years to come.

ResMed Inc. (ASX: RMD)

Not far behind CSL for me would be ResMed. This medical device company is one of my favourite shares on the Australian share market and potentially a great buy and hold option. ResMed is a leading player in a sleep treatment market which is expected to grow strongly over the next decade. In light of this, recent earnings accretive acquisitions, and its focus on software, I believe ResMed is well-positioned to continue its solid sales and earnings growth for the foreseeable future.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

4 top ASX growth shares to buy and hold

Analysts think these stocks are in the buy zone right now.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Here are 4 exciting ASX growth stocks that brokers love in 2024

Brokers think investors should be snapping up these growth stocks.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Growth Shares

How I'd use ASX growth shares to turn $1,000 into $10,000

Choosing the right growth shares can add plenty of bang to your buck.

Read more »

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »